Abstract
In this work, we report the synthesis and characterization of three novel copper(II) complexes of naphthyl derived 3-hydroxy-4-pyridinone chelators. Their antibacterial activity against several Gram-positive and Gram-negative reference strains and multidrug-resistant clinical isolates was assessed through determination of the minimum inhibitory concentration (MIC). The complex Cu(naph1pp) 2 shows the highest antibacterial activity, including against multidrug-resistant isolates, nonetheless, being more active against Gram-positive than Gram-negative bacteria. Cu(naph1pp) 2 was further explored in combinatorial tests with ciprofloxacin against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VRE). The combination of Cu(naph1pp) 2 and ciprofloxacin is considered additive, i.e., the effect of the two compounds combined is stronger than that of the individual compounds in the equivalent concentration.
| Original language | English |
|---|---|
| Article number | 110704 |
| Journal | Journal of Inorganic Biochemistry |
| Volume | 197 |
| DOIs | |
| Publication status | Published - Aug 2019 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- 3-hydroxy-4-pyridinones
- Antibacterial activity
- Copper(II) complexes
- Multidrug-resistant isolates
- Synergy with ciprofloxacin
Fingerprint
Dive into the research topics of 'Antibacterial activity of naphthyl derived bis-(3-hydroxy-4-pyridinonate) copper(II) complexes against multidrug-resistant bacteria'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver